Human cancer cell proteomics identifies proteins that fail to be degraded upon treatment with a selective autophagy inhibitor
Ontology highlight
ABSTRACT: To identify the subproteome degraded by lysosomes in human cancer cells, we compared whole cell proteomes of wild-type and autophagy-deficient non-small cell lung cancer cells in the presence or absence of a lysosomal degradation inhibitor (N/L). Further, we compared whole cell proteomes of cells treated with a selective autophagy inhibitor in the presence or absence of N/L to identify lysosome substrate proteins that fail to be degraded upon treatment with this small molecule.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
SUBMITTER:
Simone Sidoli
LAB HEAD: Simone Sidoli
PROVIDER: PXD061323 | Pride | 2025-05-03
REPOSITORIES: Pride
ACCESS DATA